Association Between Multiple Lines of Active Therapy and Prognosis in Esophageal Squamous Cell Carcinoma.

Ying YangJun JiaZhiwei SunChuanling LiuYanjie XiaoJing YuFeng DuXiaodong Zhang

Published in: Cancer management and research (2020)

Multiple lines of active treatment are related to prolonged survival in recurrent and metastatic ESCC patients, and adverse effects are acceptable. Comprehensive therapy modalities are recommended.

Keyphrases

end stage renal disease
ejection fraction
chronic kidney disease
squamous cell carcinoma
small cell lung cancer
peritoneal dialysis
prognostic factors
stem cells
patient reported outcomes
replacement therapy
bone marrow
mesenchymal stem cells
free survival
patient reported